Literature DB >> 4537478

Seroimmunity to poliomyelitis in Sweden after the use of inactivated poliovirus vaccine for 10 years.

M Böttiger, B Zetterberg, C R Salenstedt.   

Abstract

This study was undertaken in 1968 in collaboration with the World Health Organization as part of a co-operative evaluation of vaccination programmes. The situation in Sweden was of particular interest as only inactivated vaccines had been used for immunization against poliomyelitis. The WHO programme includes evaluation of both seroimmunity and resistance to poliovirus infection but the present report concerns only the serological studies.About 3 000 people, selected on a statistical basis as being a representative sample of the Swedish population, were sent questionnaires concerning their vaccinations against poliomyelitis. Answers were returned by 90% of the sample population and blood samples were collected from 2 294 persons. More than 95% of subjects under 30 years of age had received 2 or more injections, but the proportion of vaccinated individuals decreased slightly among people over 30 years of age. In the oldest age group questioned (60-70 years) only 20% had been vaccinated. Antibodies to the 3 types of poliovirus were present in more than 95% of the sera in all age groups except two. Samples seronegative to one or more types of virus were found in about 15% of people in the oldest age group and among children vaccinated during the first years of poliovirus vaccination (1957-61).

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4537478      PMCID: PMC2480706     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  3 in total

1.  The immune response to vaccination with inactivated poliovirus vaccine in Sweden.

Authors:  M Böttiger; L Arro; H Lundbeck; C R Salenstedt
Journal:  Acta Pathol Microbiol Scand       Date:  1966

2.  Immunization with inactivated poliovirus vaccine and attenuated type 3 poliovirus. I. Vaccination with the WM3 strain in 20 families.

Authors:  M Böttiger; R Lagercrantz
Journal:  J Pediatr       Date:  1969-07       Impact factor: 4.406

3.  Developing gap in immunity to poliomyelitis in an urban area.

Authors:  J L Melnick; M Burkhardt; L H Taber; P N Erckman
Journal:  JAMA       Date:  1969-08-25       Impact factor: 56.272

  3 in total
  7 in total

1.  Antibody status to poliomyelitis, measles, rubella, diphtheria and tetanus, Ontario, 1969-70: deficiencies discovered and remedies required.

Authors:  D R MacLeod; W K Ing; R J Belcourt; E W Pearson; J S Bell
Journal:  Can Med Assoc J       Date:  1975-10-04       Impact factor: 8.262

2.  Experiences from investigations of virus isolations from sewage over a two year period with special regard to polioviruses.

Authors:  M Böttiger
Journal:  Arch Gesamte Virusforsch       Date:  1973

3.  Persistence of poliovirus-neutralizing antibodies 2-16 years after immunization with live attenuated vaccine. A seroepidemiologic survey in the mainland of Venice.

Authors:  R Trivello; G Renzulli; G Farisano; C Bonello; M Moschen; V Gasparini; G Benussi
Journal:  Epidemiol Infect       Date:  1988-12       Impact factor: 2.451

4.  Epidemiological models of poliomyelitis and measles and their application in the planning of immunization programmes.

Authors:  B Cvjetanović; B Grab; H Dixon
Journal:  Bull World Health Organ       Date:  1982       Impact factor: 9.408

Review 5.  Wanted, dead or alive: new viral vaccines.

Authors:  Ian J Amanna; Mark K Slifka
Journal:  Antiviral Res       Date:  2009-09-04       Impact factor: 5.970

Review 6.  Is EU/EEA population protected from polio?

Authors:  Dre Nijsten; P Carrillo-Santisteve; A Miglietta; J Ruitenberg; P L Lopalco
Journal:  Hum Vaccin Immunother       Date:  2015-04-21       Impact factor: 3.452

7.  Inactivated polio vaccine: its proposed role in the final stages of polio eradication.

Authors:  Robert Davis; Robin Biellik
Journal:  Pan Afr Med J       Date:  2013-03-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.